Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Fred Hutch Cancer Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Fred Hutch Cancer Center brings 60 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2319. Its program centres on transplant, cell therapy and blood cancers, with a strong thread of genomic testing. It covers topics such as CAR T cells for acute myeloid leukemia and fecal microbiota transplantation to prevent graft-versus-host disease.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
Independent nonprofit cancer research and treatment center in Seattle; Washington's only NCI-designated cancer center.
Booth
Exhibiting at Booth 2319
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Consensus or Controversy? Documenting And Discussing Investigators’ Approaches to the Management of Patients with Chronic Lymphocytic Leukemia
How clinical investigators differ on managing chronic lymphocytic leukemia, comparing their answers on hard cases alongside current data and ongoing research.
Lymphoma
Symposium
Fri Dec 11
11:00am–2:00pm
Medical Crossfire®: Translating Evolving Standards of Care in Newly Diagnosed Multiple Myeloma Into Individualized Treatment Strategies
Choosing four-drug starting regimens for newly diagnosed myeloma, using residual disease tests to guide therapy, and managing new side effects.
Myeloma
Symposium
Fri Dec 11
3:00pm–6:00pm
Immune Therapy for Myeloma: From CAR T and T-Cell Engagers to Community Care
Sequencing CAR-T and T-cell engagers for relapsed myeloma, when to refer, managing toxicity, and options after B-cell maturation antigen therapy fails.
Myeloma · Cell & gene
Symposium
Fri Dec 11
3:00pm–6:00pm
ITP at a Crossroads: Closing Knowledge Gaps in Pathophysiology, Treatment Selection, and Patient-Centered Care
Personalizing immune thrombocytopenia care beyond platelet counts, weighing new therapies alongside fatigue, cognition, heavy periods, and quality of life.
Clotting
Talk
Sat Dec 12
2:00pm–3:15pm
Viral Vector-Mediated In Vivo Hematopoietic Stem Cell Gene Therapy: Targets, Delivery, and Selection
Delivering gene therapy to blood stem cells with viral vectors, plus surface marker edits that let corrected cells be enriched inside the body.
Cell & gene
Talk
Mon Dec 14
10:30am–11:45am
Cellular Therapies for Severe Autoimmune Disease: From Case Series to Multicenter Trials and Hematologic Applications
How cell therapy for severe autoimmune disease moved from case reports to larger trials, with results, safety, durability and patient selection.
Cell & gene
Session
Mon Dec 14
10:30am–11:45am
Rebooting the Immune System with Cellular Therapies
Stem cell transplant and CAR-T as a way to reset the immune system in severe autoimmune disease, with outcomes and the biology behind them.
Cell & gene

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Fred Hutch Cancer Center

Tell us what you sell and we’ll find the people at Fred Hutch Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction